Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Elias

Dermatology West Orange, NJ Doctor of Osteopathy

NPI 1710378690 CMS profile 6406268

347 Mount Pleasant Ave Ste 103, West Orange, NJ 07052

Open in the dashboard

General payments

$2,875

182 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Elias of West Orange, NJ is reported in the CMS Open Payments database as having received $2,875 across 182 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 53rd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $533 36
2024 General $391 29
2023 General $550 23
2022 General $398 24
2021 General $635 44
2020 General $261 18
2019 General $107 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Elias
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Charles Elias were reported at $533. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Charles Elias Dermatology median Middle half National median
2019 $107 $454 $129–$1,240 $163
2020 $261 $235 $81–$756 $114
2021 $635 $377 $108–$1,108 $132
2022 $398 $514 $143–$1,391 $149
2023 $550 $607 $159–$1,674 $160
2024 $391 $751 $204–$1,903 $164
2025 $533 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Biotech, Inc. $459 16 payments
  2. AbbVie, Inc. $402 29 payments
  3. Novartis Pharmaceuticals Corporation $279 13 payments
  4. E.R. Squibb & Sons, L.L.C. $196 14 payments
  5. Ortho Dermatologics, a division of Bausch Health US, LLC $140 10 payments
  6. Lilly USA, LLC $139 10 payments
  7. Pfizer Inc. $111 7 payments
  8. LEO Pharma Inc. $111 8 payments
  9. Genzyme Corporation $105 7 payments
  10. Sun Pharmaceutical Industries Inc. $101 3 payments
  11. Other $833 65 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,489 176 payments
  2. Education $387 6 payments
Products named General payments · program years 2019–2025
  1. TREMFYA $455 14 payments
  2. SOTYKTU $196 14 payments
  3. SKYRIZI Immunology $180 14 payments
  4. SKYRIZI Immunology $166 11 payments
  5. DUPIXENT Immunology $155 10 payments
  6. TALTZ $119 9 payments
  7. DUOBRII $111 8 payments
  8. COSENTYX $100 6 payments
  9. OPZELURA $81 5 payments
  10. DUPIXENT Inflammation And Immunology $69 5 payments
  11. Other $1,226 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

500

Median for Dermatology: 534

Drug cost

$38,221

Median for Dermatology: $67,151

Branded share of claims

4.6%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jublia Efinaconazole Brand 23 $25,506
Fluocinonide Generic 87 $3,434
Fluorouracil Generic 49 $2,854
Clobetasol Propionate Generic 43 $1,441
Metronidazole Generic 23 $1,264
Triamcinolone Acetonide Generic 146 $1,260
Doxycycline Hyclate Generic 22 $1,044
Ketoconazole Generic 45 $658
Ciclopirox Generic 18 $435
Hydrocortisone Generic 33 $205

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$141,166

Medicare's payments for the services billed

Medicare patients

696

Average age 75

Services billed

3,133

295 women, 401 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 44%
Diabetes 30%
Ischemic heart disease 30%
Atrial fibrillation 18%
Cancer 17%
Chronic kidney disease 16%
COPD 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 12 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $140
$140 — —
SKYRIZI
  • AbbVie, Inc. $47
$47 — —
CIBINQO
  • PFIZER INC. $36
$36 — —
COSENTYX
  • Novartis Pharmaceuticals Corporation $22
$22 — —
Otezla
  • Amgen Inc. $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 12 in the dashboard with a free account

Records

182 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record